Dexamethasone regulates differential expression of carboxylesterase 1 and carboxylesterase 2 through activation of nuclear receptors

Abstract

Carboxylesterases (CESs) play important roles in the metabolism of endogenous and foreign compounds in physiological and pharmacological responses. The aim of this study was to investigate the effect of dexamethasone at different doses on the expression of CES1 and CES2. Imidapril and irinotecan hydrochloride (CPT-11) were used as special substrates for CES1 and CES2, respectively. Rat hepatocytes were cultured and treated with different concentrations of dexamethasone. The hydrolytic activity of CES1 and CES2 was tested by incubation experiment and their expression was quantitated by real-time PCR. A pharmacokinetic study was conducted in SD rats to further evaluate the effect of dexamethasone on CESs activity in vivo. Western blotting was performed to investigate the regulatory mechanism related to pregnane X receptor (PXR) and glucocorticoid receptor (GR). The results showed that exposure of cultured rat hepatocytes to nanomolar dexamethasone inhibited the imidapril hydrolase activity, which was slightly elevated by micromolar dexamethasone. For CES2, CPT-11 hydrolase activity was induced only when dexamethasone reached micromolar levels. The real-time PCR demonstrated that CES1 mRNA was markedly decreased by nanomolar dexamethasone and increased by micromolar dexamethasone, whereas CES2 mRNA was significantly increased by micromolar dexamethasone. The results of a complementary animal study showed that the concurrent administration of dexamethasone significantly increased the plasma concentration of the metabolite of imidapril while the ratio of CPT-11 to its metabolite SN-38 was significantly decreased. PXR protein was gradually increased by serial concentrations of dexamethasone. However, only nanomolar dexamethasone elevated the level of GR protein. The different concentrations of dexamethasone required suggested that suppression of CES1 may be mediated by GR whereas the induction of CES2 may result from the role of PXR. It was concluded that dexamethasone at different concentrations can differentially regulate CES1 and CES2.

Keywords

dexamethasone / carboxylesterases / liver / imidapril / irinotecan hydrochloride

References

[1] SatohT., TaylorP., BosronW.F., et al.. Current progress on esterases: from molecular structure to function. Drug Metab Dispos, 2002, 30(5): 488-493

[2] SatohT., HosokawaM.. Structure, function and regulation of carboxylesterases. Chem Biol Interact, 2006, 162(3): 195-211

[3] LiuD., GaoJ., ZhangC.L., et al.. Identification of carboxylesterases expressed in rat intestine and effects of their hydrolyzing activity in predicting first-pass metabolism of ester prodrugs. Die Pharmazie, 2011, 66(11): 888-893

[4] ZhuW., SongL., ZhangH., et al.. Dexamethasone differentially regulates expression of carboxylesterase genes in humans and rats. Drug Metab Dispos, 2000, 28(2): 186-191

[5] HosokawaM., HattoriK., SatohT.. Differential responses of rat hepatic microsomal carboxylesterase isozymes to glucocorticoids and pregnenolone 16 alpha-carbonitrile. Biochem Pharmacol, 1993, 45(11): 2317-2322

[6] MorganE.W., YanB., GreenwayD., et al.. Regulation of two rat liver microsomal carboxylesterase isozymes: species differences, tissue distribution, and the effects of age, sex, and xenobiotic treatment of rats. Arch Biochem Biophys, 1994, 315(2): 513-526

[7] HattoriK., IgarashiM., ItohM., et al.. Purification and characterization of glucocorticoid-inducible steroid esterase in rat hepatic microsomes. Biochem Pharmacol, 1992, 43(9): 1929-1937

[8] FurihataT., HosokawaM., FujiiA., et al.. Dexamethasone-induced methylprednisolone hemisuccinate hydrolase: its identification as a member of the rat carboxylesterase 2 family and its unique existence in plasma. 2 family and its unique existence in plasma. Biochem Pharmacol, 2005, 69(8): 1287-1297

[9] SatohT., HosokawaM.. The mammalian carboxylesterases: from molecules to functions. Annu Rev Pharmacol Toxicol, 1998, 38: 257-288

[10] ShiD., YangJ., YangD., et al.. Dexamethasone suppresses the expression of multiple rat carboxylesterases through transcriptional repression: evidence for an involvement of the glucocorticoid receptor. Toxicology, 2008, 254(1–2): 97-105

[11] WaxmanD.J., MorrisseyJ.J., NaikS., et al.. Phenobarbital induction of cytochromes P-450. High-level long-term responsiveness of primary rat hepatocyte cultures to drug induction, and glucocorticoid dependence of the phenobarbital response. Biochem J, 1990, 27(1): 113-119

[12] TakahashiS., KatohM., SaitohT., et al.. Allosteric kinetics of human carboxylesterase 1: species differences and interindividual variability. J Pharm Sci, 2008, 97(12): 5434-5445

[13] HumerickhouseR., LohrbachK., LiL., et al.. Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2. Cancer Res, 2000, 60(5): 1189-1192

[14] GeshiE., KimuraT., YoshimuraM., et al.. A single nucleotide polymorphism in the carboxylesterase gene is associated with the responsiveness to imidapril medication and the promoter activity. Hypertens Res, 2005, 28(9): 719-725

[15] SanghaniS.P., QuinneyS.K., FredenburgT.B., et al.. Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperid ino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3. Drug Metab Dispos, 2004, 32(5): 505-511

[16] MiettinenS., YlikomiT.. Concomitant exposure of ovarian cancer cells to docetaxel, CPT-11 or SN-38 and adenovirus-mediated p53 gene therapy. Anticancer Drugs, 2009, 20(7): 589-600

[17] MasakiK., HashimotoM., ImaiT.. Intestinal first-pass metabolism via carboxylesterase in rat jejunum and ileum. Drug Metab Dispos, 2007, 35(7): 1089-1095

[18] SilvaE.J., QueirozD.B., HondaL., et al.. Glucocorticoid receptor in the rat epididymis: expression, cellular distribution and regulation by steroid hormones. Mol Cell Endocrinol, 2010, 325(1–2): 64-77

[19] XuC., WangX., StaudingerJ.L.. Regulation of tissue-specific carboxylesterase expression by pregnane x receptor and constitutive androstane receptor. Drug Metab Dispos, 2009, 37(7): 1539-1547

[20] OkumuraM., IwakiriT., TakagiA., et al.. Hepatocyte growth factor suppresses the anticancer effect of irinotecan by decreasing the level of active metabolite in HepG2 cells. Biochem Pharmacol, 2011, 82(11): 1720-1730

[21] YangD., WangX., ChenY.T., et al.. Pyrethroid insecticides: isoform-dependent hydrolysis, induction of cytochrome P450 3A4 and evidence on the involvement of the pregnane X receptor. Toxicol Appl Pharmacol, 2009, 237(1): 49-58

[22] AntonijevicB., BokonjicD., StojiljkovicM.P., et al.. Efficacy of trimedoxime in mice poisoned with dichlorvos, heptenophos or monocrotophos. Basic Clin Pharmacol Toxicol, 2005, 96(2): 111-117

[23] EngH., NiosiM., McDonaldT.S., et al.. Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor. Xenobiotica, 2010, 40(6): 369-380

[24] MakhaevaG.F., AksinenkoA.Y., SokolovV.B., et al.. Kinetics and mechanism of inhibition of serine esterases by fluorinated aminophosphonates. Chem Biol Interact, 2010, 187(1–3): 177-184

[25] CrowJ.A., MiddletonB.L., BorazjaniA., et al.. Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages. Biochim Biophys Acta, 2008, 1781(10): 643-654

[26] FujitaK., SparreboomA.. Pharmacogenetics of irinotecan disposition and toxicity: a review. Curr Clin Pharmacol, 2010, 5(3): 209-217

[27] StaudingerJ.L., XuC., CuiY.J., et al.. Nuclear receptor-mediated regulation of carboxylesterase expression and activity. Expert Opin Drug Metab Toxicol, 2010, 6(3): 261-271

[28] MandrichL., MeroneL., MancoG.. Structural and kinetic overview of the carboxylesterase EST2 from alicyclobacillus acidocaldarius: a comparison with the other members of the HSL family. Protein Pept Lett, 2009, 16(10): 1189-1200

[29] TullyD.B., BaoW., GoetzA.K., et al.. Gene expression profiling in liver and testis of rats to characterize the toxicity of triazole fungicides. Toxicol Appl Pharmacol, 2006, 215(3): 260-273

[30] GoetzA.K., BaoW., RenH., et al.. Gene expression profiling in the liver of CD-1 mice to characterize the hepatotoxicity of triazole fungicides. Toxicol Appl Pharmacol, 2006, 215(3): 274-284